Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) – Analysis By Application, Type, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) – Analysis By Application, Type, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

  • June 2021 •
  • 200 pages •
  • Report ID: 6102457 •
  • Format: PDF
Executive Summary
Global Chloromethyl Isopropyl Carbonate Market (CMIC) valued at USD 26.67 Million and xx Metric Tonnes by volume in the year 2020, form an integral part of the important ingredients of the pharmaceutical industry. Chloromethyl Isopropyl Carbonate is one major chemical that is used commonly for making drugs to fight AIDS virus and other diseases like Hepatitis B. In fact, it is a key component of the drug Tenofovir that is useful to cure Hepatitis. A number of companies use this pharma intermediate or specialty chemical for curing chronic diseases like AIDS and hepatitis B.

Chloromethyl Isopropyl Carbonate is mainly used in pharmaceutical industry as key intermediate for anti-AIDS and anti-hepatitis B drug Tenofovir. There are also many chemicals which are used for manufacturing of Anti-Retroviral. During the pandemic situation caused by the COVID-19, consumption of anti-viral medicines have grown in general, resulting in favourable situation for raw material producers of these drugs including companies manufacturing Chloromethyl Isopropyl Carbonate and other chemicals used in manufacturing of Anti-Viral Drugs.

Asia Pacific dominates the Chloromethyl Isopropyl Carbonate Market on account of the increasing demand for the antiviral drugs because of the growing elderly population in the region that are more prone to contracting viral diseases. The market uptake of antiviral drugs is influenced by favourable regulatory policies and initiatives taken by the government.

Moreover, the increasing investment and funding by the government and private organizations in developing countries such as China and India encourages new market entrants. Major biopharmaceutical firms in the Asia Pacific region are focusing on the development of host-targeting antiviral medicines. AbbVie Inc., Gilead Sciences, Merck & Co., Bristol-Myers Squibb, GSK and Aurobindo Pharma Ltd. are among major competitors in Asia Pacific antiviral drugs market. To establish a presence in the region, these organizations are pursuing various market tactics such as cooperation, product innovation, mergers, and acquisitions.

Scope of the Report
• The report presents the analysis of Chloromethyl Isopropyl Carbonate Market for the historical period of 2016-2020 and the forecast period of 2021-2026.

• The report analyses Chloromethyl Isopropyl Carbonate Market By Value and By Volume (By Production).

• The report analyses Chloromethyl Isopropyl Carbonate Market By Application (Human Immunodeficiency Virus Intermediates, Hepatitis B Virus Intermediates and Others).

• The report further assesses the Chloromethyl Isopropyl Carbonate Market By Type (Purity 98% and Others).

• The Global Chloromethyl Isopropyl Carbonate has been analysed By Region (North America, Europe and Asia Pacific) and By Country (United States, Canada, Germany, United Kingdom, China and India).

• The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions. Also, the attractiveness of the market has been presented By Region, By Application and By Type. Additionally, trends, drivers and challenges of the industry has been analysed in the report.

• The companies analysed in the report include Chemcon Speciality Chemicals Limited, Paushak, Atul Ltd., Anshul Specialty Molecules Private Limited, Santa Cruz Biotechnology and Pingyuan Xinda Chemical Co.,Ltd.

Key Target Audience

• Healthcare and Pharmaceutical Companies

• Traders, Importers, and Exporters

• Raw Material Suppliers and Distributors

• Government and Research Organisations

• Consulting and Advisory Firms

• Investment Banks and Equity Firms
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.